Evidence map›Paper›PMID 19542217›Full record

ArticleThe Journal of biological chemistry2009

Antigen-specific proteolysis by hybrid antibodies containing promiscuous proteolytic light chains paired with an antigen-binding heavy chain.

Gopal Sapparapu, Stephanie A Planque, Yasuhiro Nishiyama, Steven K Foung, Sudhir Paul

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Specific amyloid β clearance by a catalytic antibody construct.The Journal of biological chemistry · 2015
    Article
  5. Article
  6. Article
  7. Constant domain-regulated antibody catalysis.The Journal of biological chemistry · 2012
    Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Gopal SapparapuChemical Immunology Research Center, Department of Pathology and Laboratory Medicine, University of Texas Houston Medical School, Houston, Texas 77030, USA.
Stephanie A Planque
Yasuhiro Nishiyama
Steven K Foung
Sudhir Paul
The University of Texas Health Science Center at Houston · USStanford University · US

Funding

Neutralizing Antibodies to Hepatitis CR01HL079381 · NHLBI · STANFORD UNIVERSITY · PI FOUNG, STEVEN · 2004 to 2008
$2.8M
NHLBI NIH HHS R01 HL079381
6 · The paper itself

Abstract

The antigen recognition site of antibodies consists of the heavy and light chain variable domains (V(L) and V(H) domains). V(L) domains catalyze peptide bond hydrolysis independent of V(H) domains (Mei, S., Mody, B., Eklund, S. H., and Paul, S. (1991) J. Biol. Chem. 266, 15571-15574). V(H) domains bind antigens noncovalently independent of V(L) domains (Ward, E. S., Güssow, D., Griffiths, A. D., Jones, P. T., and Winter, G. (1989) Nature 341, 544-546). We describe specific hydrolysis of fusion proteins of the hepatitis C virus E2 protein with glutathione S-transferase (GST-E2) or FLAG peptide (FLAG-E2) by antibodies containing the V(H) domain of an anti-E2 IgG paired with promiscuously catalytic V(L) domains. The hybrid IgG hydrolyzed the E2 fusion proteins more rapidly than the unpaired light chain. An active site-directed inhibitor of serine proteases inhibited the proteolytic activity of the hybrid IgG, indicating a serine protease mechanism. The hybrid IgG displayed noncovalent E2 binding in enzyme-linked immunosorbent assay tests. Immunoblotting studies suggested hydrolysis of FLAG-E2 at a bond within E2 located approximately 11 kDa from the N terminus. GST-E2 was hydrolyzed by the hybrid IgG at bonds in the GST tag. The differing cleavage pattern of FLAG-E2 and GST-E2 can be explained by the split-site model of catalysis, in which conformational differences in the E2 fusion protein substrates position alternate peptide bonds in register with the antibody catalytic subsite despite a common noncovalent binding mechanism. These studies provide proof-of-principle that the catalytic activity of a light chain can be rendered antigen-specific by pairing with a noncovalently binding heavy chain subunit.

Indexed as

AnimalsAntibodies, CatalyticCatalysisHepatitis C AntibodiesHepatitis C AntigensHumansHydrolysisImmunoglobulin GImmunoglobulin Heavy ChainsImmunoglobulin Light ChainsImmunoglobulin Variable RegionRecombinant Fusion ProteinsViral Envelope ProteinsAntibodies, Catalyticglycoprotein E2, Hepatitis C virusHepatitis C AntibodiesHepatitis C AntigensImmunoglobulin GImmunoglobulin Heavy ChainsImmunoglobulin Light ChainsImmunoglobulin Variable RegionRecombinant Fusion ProteinsViral Envelope Proteins

Identifiers

PMID19542217
PMCPMC2782051
OpenAlexW2089528782

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.